Skip to main content
Clinical Trials/NCT04538001
NCT04538001
Unknown
N/A

A Prospective, Multicenter, Randomized Trial in Evaluating the Safety and Efficacy of the Rotator Cuff Function Restoration Balloon in Patients With Irreparable Rotator Cuff Tear

Shanghai MicroPort Medical (Group) Co., Ltd.0 sites112 target enrollmentSeptember 1, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Rotator Cuff Tears
Sponsor
Shanghai MicroPort Medical (Group) Co., Ltd.
Enrollment
112
Primary Endpoint
Change in Constant-Murley shoulder outcome score
Last Updated
5 years ago

Overview

Brief Summary

This study is a prospective, multicenter, randomized, controlled clinical study aiming to evaluate the safety and efficacy of the rotator cuff function restoration balloon in patients with irreparable rotator cuff tear compared to partial repair of the rotator cuff.

Detailed Description

This prospective, multicenter, randomized controlled clinical study is designed to enroll 112 subjects with irreparable rotator cuff tear and randomly assign them to the trial and control groups on a 1:1 basis.The experimental group was treated with rotator cuff restoration balloon, and the control group was treated with rotator cuff partial repair. The main end point of the study was improvement of the Constant Score at 6 months after the surgery. All subjects were followed up clinically at 1 day, 6 weeks, 3 months, 6 months and 1 year after the surgery, and were followed up with imaging examination at 3 months, 6 months and 1 year after the surgery.

Registry
clinicaltrials.gov
Start Date
September 1, 2020
End Date
September 1, 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Persistent pain and failure of non-operative treatment of the affected shoulder for at least 3 months
  • Failed non-operative treatment of at least 3 months
  • Patients are able to understand the purpose of the trial, voluntarily participated in and acknowledged the risks and benefits by signing the informed consent form
  • Patients can complete the clinical trial psychologically, physiologically and mentally, and can comply with all post-operative evaluations and visits
  • Posterosuperior rotator cuff tear diagnosed by MRI in the past 6 months, defined as the rotator cuff tear involving supraspinatus and infraspinatus muscles, and could be combined with type I subscapular muscle injury.
  • Evidence of any one of the following conditions confirmed by MRI:
  • (1) The rotator cuff tear measuring \>3cm in size; (2) involving ≥ 2 tendons; (3) stage 3 or 4 fatty infiltration according to Goutallier Classification; (4) acromiohumeral interval \<7mm.
  • All subjects meeting the above inclusion criteria will undergo arthroscopic debridement, if the tear size is still \>3cm at medial to lateral direction, and the superior edge cannot be fixed to the footprint area to overlap bone coverage for complete repair.

Exclusion Criteria

  • Known allergy to the balloon material (polyethylene)
  • Evidence of osteoarthritis or cartilage damage in the shoulder
  • Evidence of gleno-humeral instability or axillary nerve palsy
  • Evidence of major joint trauma, infection, or necrosis in the shoulder
  • Previous surgery of the index shoulder in the past 1 year, excluding diagnostic arthroscopy
  • Shoulder pain due to other unknown causes
  • Major medical condition or known drug or alcohol abuses that could affect quality of life and influence the results of the study.
  • Subjects with poor compliance, unable to complete the trial according to the requirements or for other reasons, or considered not to be suitable for inclusion by investigators.
  • Concurrent participation in any other invasive clinical study one month prior to enrollment to the study and during the entire study period.
  • Acute infection requiring antibiotics

Outcomes

Primary Outcomes

Change in Constant-Murley shoulder outcome score

Time Frame: 6 months post operation

Change in Constant-Murley shoulder outcome score and improvement compare to baseline

Secondary Outcomes

  • Acromiohumeral distance(3 months, 6months, 1year post operation)
  • Change in Constant-Murley shoulder outcome score(3 months, 1year post operation)
  • Change in American Shoulder and Elbow Score (ASES)(3 months, 6 months and 1year post operation)
  • Change in pain score(1 day, 6weeks, 3 months, 6months, 1year post operation)
  • Change in range of motion(3 months, 6months, 1year post operation)
  • Safety assessment(Peri-operation and 1 day, 6weeks, 3 months, 6months, 1year post operation)

Similar Trials